| Q36744213 | Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model |
| Q36234238 | Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans |
| Q36020820 | Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice |
| Q47135495 | Antidepressant-like effects of fenofibrate in mice via the hippocampal brain-derived neurotrophic factor signalling pathway |
| Q58798790 | Biomarkers for PTSD at the Interface of the Endocannabinoid and Neurosteroid Axis |
| Q35896661 | Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity |
| Q37998561 | CB1 receptor antagonists: new discoveries leading to new perspectives |
| Q40245342 | Cannabinoid 1 receptors are critical for the innate immune response to TLR4 stimulation. |
| Q64073287 | Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology |
| Q47661316 | Cannabinoid Modulation of the Stressed Hippocampus |
| Q52652770 | Cannabinoid Receptors, Mental Pain and Suicidal Behavior: a Systematic Review. |
| Q28277871 | Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease |
| Q37760048 | Cannabinoid conditioned reward and aversion: behavioral and neural processes. |
| Q48191152 | Cannabinoids prevent the differential long-term effects of exposure to severe stress on hippocampal- and amygdala-dependent memory and plasticity. |
| Q35784024 | Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence |
| Q36888657 | Cyclooxygenase-2 inhibition reduces stress-induced affective pathology. |
| Q30498533 | Deficiency in Endocannabinoid Signaling in the Nucleus Accumbens Induced by Chronic Unpredictable Stress |
| Q34104954 | Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure |
| Q104459044 | Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system |
| Q30843851 | Endocannabinoid signalling modulates susceptibility to traumatic stress exposure |
| Q37887826 | Endocannabinoids and stress |
| Q33583792 | Endocannabinoids and striatal function: implications for addiction-related behaviours |
| Q33565499 | Endocannabinoids differentially modulate synaptic plasticity in rat hippocampal CA1 pyramidal neurons |
| Q59791745 | Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression |
| Q34660430 | Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus. |
| Q58855638 | Harnessing the pyrroloquinoxaline scaffold for FAAH and MAGL interaction: definition of the structural determinants for enzyme inhibition |
| Q57021638 | Impact of FAAH genetic variation on fronto-amygdala function during emotional processing |
| Q50555809 | Inhibition of anandamide hydrolysis dampens the neuroendocrine response to stress in neonatal rats subjected to suboptimal rearing conditions. |
| Q35130530 | Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey. |
| Q43094385 | Inhibition of monoamine oxidase activity by cannabinoids. |
| Q57176238 | Integrating endocannabinoid signaling in the regulation of anxiety and depression |
| Q50982694 | Involvement of 2-arachidonoylglycerol signaling in social challenge responding of male CD1 mice. |
| Q34153898 | Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids |
| Q37332115 | Modulating the modulators: interaction of brain norepinephrine and cannabinoids in stress |
| Q33620621 | Monoacylglycerol lipase inhibition blocks chronic stress-induced depressive-like behaviors via activation of mTOR signaling |
| Q37617606 | Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses |
| Q24623179 | Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders |
| Q38280778 | Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapses |
| Q34209630 | N-palmitoylethanolamide, an endocannabinoid, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice |
| Q36366731 | Neurobiological Interactions Between Stress and the Endocannabinoid System. |
| Q27026698 | Neurobiology of chronic mild stress: parallels to major depression |
| Q64285500 | Noradrenergic depletion causes sex specific alterations in the endocannabinoid system in the Murine prefrontal cortex |
| Q37650195 | Novel discoveries in understanding the complexities of epilepsy and major depression |
| Q34025536 | Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. |
| Q38044652 | Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB(1) receptor antagonists |
| Q36004536 | Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway |
| Q37636276 | Prefrontal deficits in a murine model overexpressing the down syndrome candidate gene dyrk1a. |
| Q37386356 | Resilience to meet the challenge of addiction: psychobiology and clinical considerations |
| Q35592057 | Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation |
| Q47284001 | Schizophrenia and depression, two poles of endocannabinoid system deregulation |
| Q38161850 | Selective MAO-B inhibitors: a lesson from natural products |
| Q33819279 | Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation |
| Q67223779 | The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review |
| Q39214399 | The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system |
| Q37279826 | Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses |
| Q35972392 | Ultrastructural evidence for synaptic contacts between cortical noradrenergic afferents and endocannabinoid-synthesizing post-synaptic neurons. |